The Ebola death toll has risen to 61 in the Democratic Republic of Congo, where health officials are working to contain the outbreak in the North Kivu and Ituri provinces. Most of the fatalities have
GENEVA - The World Health Organization published a new classification of antibiotics Tuesday that aims to fight drug resistance, with penicillin-type drugs recommended as the first line of defense and
Interdisciplinary research at the University of Leicester has explored the impact of black carbon on bacteria in the respiratory tract Researchers from the University of Leicester have for the first
There is hope for over 37 million people infected with HIV globally after five people were reported to be virus-free after undergoing treatment. According to a study published in New Scientist, a new vaccine
The Pharmaceutical Society of Nigeria (PSN) has warned that the prices of essential medicines in the country, such as anti-malarial drugs and antibiotics have risen by over 150 per cent in less than two
The National Centre for Disease Control has faulted the claim by a Nigerian professor of discovering the cure for HIV. Maduike Ezeibe, a Professor of Veterinary Medicine and Clinical Virology at the Michael
Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show it offers 100% protection. The vaccine is now being fast-tracked through
In their paper, Neutralization Mechanism of a Highly Potent Antibody Against Zika Virus, Associate Professor Lok Shee-Mei and her team at the Emerging Infectious Disease Programme of Duke-NUS further explored
The world is in the grip of a global crisis that kills the equivalent of the populations of Philadelphia, Kampala or Prague - around 1.6 million each year. A new report by a University of Manchester
One drug can treat three deadly and neglected infections - Chagas disease, leishmaniasis and sleeping sickness - animal studies show. It has been described as a "new hope" for tackling the parasitic infections
A new vaccine allows pneumonia-causing bacteria to colonize inside the body, springing into action only if the bacteria pose a threat. The breakthrough approach, coupled with the protein-based vaccine's
